Literature DB >> 1796226

Schistosoma mansoni and S. japonicum: decline of antibodies against diagnostic adult worm antigens (Sm31/32) following praziquantel treatment of mice.

A Ruppel1, Y Xing, R Dell, P Numrich, Y E Shi.   

Abstract

Mice were infected with 10, 100 or 200 cercariae of Schistosoma mansoni or S. japonicum and treated between one and two months later with two doses of praziquantel. At this time, the animals had high levels of antibodies against the adult worm proteins Sm31/32 (schistosome cathepsin B and haemoglobinase). Antibody levels were followed up for about one more year by Western blots and ELISA using purified Sm31/32. Among the 34 surviving mice perfused at the end of the experiments, 14 had between 1 and 4 and one mouse had 8 residual stunted worms. In most mice without detectable worms, anti-Sm31/32 antibodies started to drop within a few months after therapy. In other animals of this group and in those harbouring residual worms, the decrease in titers was not observed or less pronounced. Thus, the presence of even one stunted worm was sufficient to induce continued high titres of antibodies. Decreasing levels of antibody against Sm31/32, however, reflected complete elimination of schistosomes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1796226

Source DB:  PubMed          Journal:  Trop Med Parasitol        ISSN: 0177-2392


  2 in total

1.  Preliminary characterization of an adult worm "vomit" preparation of Schistosoma mansoni and its potential use as antigen for diagnosis.

Authors:  Sandra Planchart; Renzo Nino Incani; Italo Mario Cesari
Journal:  Parasitol Res       Date:  2007-02-20       Impact factor: 2.289

2.  Circulating antigens in schistosomiasis: detection of 31/32-kDa proteins in sera from patients infected with Schistosoma japonicum, S. mansoni, S. haematobium, or S. intercalatum.

Authors:  Y L Li; M A Idris; M Corachan; J J Han; M Kirschfink; A Ruppel
Journal:  Parasitol Res       Date:  1996       Impact factor: 2.289

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.